$48.770
-1.975 (-4.05%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de RAPP por análisis de gráficos similares
Alphio's RAPP stock price prediction model matches the current Rapport Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $48.43 (-0.69%). The 1-week path is $48.42 (-0.72%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Rapport Therapeutics Inc?
Rapport Therapeutics Inc is a good buy right now due to its recent strong performance, with a current price of $48.77, and a significant year-to-date change of +73.50%. The company's gross margin has improved to 100% in Q1 2026, indicating a strong potential for profitability as it advances its therapies. Additionally, analysts have set price targets as high as $79.03, suggesting substantial upside from the current price. However, a risk to consider is the recent widening net loss of $56.6 million in Q2 2026, which could impact investor sentiment.
RAPP cerró en $48.77 el Friday, tras bajar -4.05%
Rapport Therapeutics Inc (RAPP) last closed at $48.77, losing -4.05%. These facts feed the 1-day and 1-week RAPP price prediction above.
Factores de la previsión
Los factores de la previsión de Rapport Therapeutics Inc (RAPP) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de RAPP, ordenadas por similitud.
Análisis de estacionalidad de RAPP
Historically the probability of a positive August return for RAPP is 47.62%. November offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de RAPP
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $13.60 | $15.67 | $17.33 | -67.87% |
| Sep 2026 | $15.49 | $17.38 | $18.58 | -64.36% |
| Oct 2026 | $11.59 | $13.51 | $13.94 | -72.30% |
| Nov 2026 | $13.96 | $15.06 | $17.94 | -69.13% |
| Dec 2026 | $13.60 | $15.18 | $17.69 | -68.87% |
En 2026, se proyecta que Rapport Therapeutics Inc (RAPP) oscile entre $11.59 y $18.58.
Previsión mensual de Rapport Therapeutics Inc para 2026
En Aug de 2026, se proyecta que Rapport Therapeutics Inc promedie $15.67, con un mínimo de $13.60 y un máximo de $17.33.
En Sep de 2026, se proyecta que Rapport Therapeutics Inc promedie $17.38, con un mínimo de $15.49 y un máximo de $18.58.
En Oct de 2026, se proyecta que Rapport Therapeutics Inc promedie $13.51, con un mínimo de $11.59 y un máximo de $13.94.
En Nov de 2026, se proyecta que Rapport Therapeutics Inc promedie $15.06, con un mínimo de $13.96 y un máximo de $17.94.
En Dec de 2026, se proyecta que Rapport Therapeutics Inc promedie $15.18, con un mínimo de $13.60 y un máximo de $17.69.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.